KEGG   PATHWAY: pvp05323
Entry
pvp05323                    Pathway                                
Name
Rheumatoid arthritis - Pteropus vampyrus (large flying fox)
Description
Rheumatoid arthritis (RA) is a chronic autoimmune joint disease where persistent inflammation affects bone remodeling leading to progressive bone destruction. In RA, abnormal activation of the immune system elevates pro-inflammatory cytokines and chemokines levels, which can promote synovial angiogenesis and leukocyte infiltration. The synovium forms a hyperplastic pannus with infiltrated macrophage-like and fibroblast-like synoviocytes and invades joints by secreting proteinases and inducing osteoclast differentiation.
Class
Human Diseases; Immune disease
Pathway map
pvp05323  Rheumatoid arthritis
pvp05323

Disease
H00630  Rheumatoid arthritis
Organism
Pteropus vampyrus (large flying fox) [GN:pvp]
Gene
105288488  VEGFA; vascular endothelial growth factor A isoform X1 [KO:K05448]
105288864  CD86; T-lymphocyte activation antigen CD86 [KO:K05413]
105289362  ATP6V0A2; V-type proton ATPase 116 kDa subunit a isoform X1 [KO:K02154]
105290186  ATP6V1F; V-type proton ATPase subunit F [KO:K02151]
105291217  TNFSF13; tumor necrosis factor ligand superfamily member 13 isoform X1 [KO:K05475]
105291392  ATP6V1H; V-type proton ATPase subunit H isoform X1 [KO:K02144]
105291526  TLR2; toll-like receptor 2 [KO:K10159]
105291621  ATP6V0A4; V-type proton ATPase 116 kDa subunit a isoform X1 [KO:K02154]
105291966  [KO:K14624]
105292131  FLT1; vascular endothelial growth factor receptor 1 [KO:K05096] [EC:2.7.10.1]
105292339  CXCL8; interleukin-8 [KO:K10030]
105292340  [KO:K05506]
105292342  [KO:K05505]
105292645  ATP6V1G1; V-type proton ATPase subunit G 1 [KO:K02152]
105292652  TLR4; toll-like receptor 4 [KO:K10160]
105292754  TNFRSF11A; tumor necrosis factor receptor superfamily member 11A [KO:K05147]
105292922  ATP6V1E2; V-type proton ATPase subunit E 2 [KO:K02150]
105293152  IL6; interleukin-6 isoform X2 [KO:K05405]
105293539  CSF2; granulocyte-macrophage colony-stimulating factor [KO:K05427]
105294740  CCL20; C-C motif chemokine 20 isoform X1 [KO:K14625]
105295447  ATP6V1C2; LOW QUALITY PROTEIN: V-type proton ATPase subunit C 2 [KO:K02148]
105295631  IL18; interleukin-18 [KO:K05482]
105295753  ATP6V1B1; V-type proton ATPase subunit B, kidney isoform [KO:K02147]
105296163  TGFB2; transforming growth factor beta-2 isoform X1 [KO:K13376]
105296552  ATP6V1B2; V-type proton ATPase subunit B, brain isoform [KO:K02147]
105296889  ATP6V1G3; V-type proton ATPase subunit G 3 [KO:K02152]
105297098  ATP6V0B; V-type proton ATPase 21 kDa proteolipid subunit isoform X1 [KO:K03661]
105297143  CSF1; macrophage colony-stimulating factor 1 isoform X1 [KO:K05453]
105297242  ATP6V1E1; V-type proton ATPase subunit E 1 [KO:K02150]
105297437  [KO:K01388] [EC:3.4.24.7]
105297467  [KO:K01394] [EC:3.4.24.17]
105298291  ANGPT1; angiopoietin-1 isoform X1 [KO:K05465]
105298421  CTLA4; cytotoxic T-lymphocyte protein 4 isoform X1 [KO:K06538]
105298423  CD28; T-cell-specific surface glycoprotein CD28 isoform X1 [KO:K06470]
105298465  TNFSF11; tumor necrosis factor ligand superfamily member 11 [KO:K05473]
105299206  TGFB3; transforming growth factor beta-3 [KO:K13377]
105299213  FOS; proto-oncogene c-Fos [KO:K04379]
105299305  ATP6V0E1; V-type proton ATPase subunit e 1 [KO:K02153]
105300870  ATP6V1C1; V-type proton ATPase subunit C 1 isoform X1 [KO:K02148]
105300960  [KO:K06752]
105300961  [KO:K06752]
105300962  [KO:K06752]
105300964  [KO:K06752]
105300969  [KO:K06752]
105300971  [KO:K06752]
105300973  [KO:K06752]
105301004  [KO:K06752]
105301039  [KO:K06752]
105301205  IL15; interleukin-15 isoform X1 [KO:K05433]
105301262  IFNG; interferon gamma [KO:K04687]
105301326  TNFSF13B; tumor necrosis factor ligand superfamily member 13B [KO:K05476]
105301478  PTH; parathyroid hormone [KO:K05261]
105302220  CD80; T-lymphocyte activation antigen CD80 [KO:K05412]
105302499  ATP6AP1; V-type proton ATPase subunit S1 [KO:K03662]
105302575  IL23A; interleukin-23 subunit alpha [KO:K05426]
105302744  ATP6V0D2; V-type proton ATPase subunit d 2 [KO:K02146]
105303028  ITGB2; integrin beta-2 [KO:K06464]
105303358  ATP6V0C; V-type proton ATPase 16 kDa proteolipid subunit [KO:K02155]
105303436  JUN; transcription factor AP-1 [KO:K04448]
105303821  CTSK; cathepsin K isoform X1 [KO:K01371] [EC:3.4.22.38]
105303967  ATP6V1A; V-type proton ATPase catalytic subunit A [KO:K02145] [EC:7.1.2.2]
105303981  IL1A; interleukin-1 alpha [KO:K04383]
105303982  IL1B; interleukin-1 beta [KO:K04519]
105304170  CXCL12; stromal cell-derived factor 1 isoform X1 [KO:K10031]
105304532  ITGAL; integrin alpha-L isoform X1 [KO:K05718]
105304790  IL17A; interleukin-17A [KO:K05489]
105304909  IL11; interleukin-11 isoform X1 [KO:K05417]
105304977  CCL5; C-C motif chemokine 5 [KO:K12499]
105304981  [KO:K05408]
105305012  [KO:K05408]
105305274  [KO:K06752]
105305323  LTB; lymphotoxin-beta isoform X1 [KO:K03157]
105305325  TNF; tumor necrosis factor [KO:K03156]
105305327  ATP6V1G2; V-type proton ATPase subunit G 2 [KO:K02152]
105305333  [KO:K06752]
105305590  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
105305635  ACP5; tartrate-resistant acid phosphatase type 5 [KO:K14379] [EC:3.1.3.2]
105305719  ATP6V0D1; V-type proton ATPase subunit d 1 isoform X1 [KO:K02146]
105306292  ATP6V0A1; V-type proton ATPase 116 kDa subunit a isoform X1 [KO:K02154]
105306474  [KO:K01365] [EC:3.4.22.15]
105306565  TCIRG1; V-type proton ATPase 116 kDa subunit a isoform X1 [KO:K02154]
105306921  [KO:K01365] [EC:3.4.22.15]
105307777  [KO:K05096] [EC:2.7.10.1]
105307945  TGFB1; transforming growth factor beta-1 [KO:K13375]
105308731  TEK; angiopoietin-1 receptor isoform X1 [KO:K05121] [EC:2.7.10.1]
105308899  [KO:K01365] [EC:3.4.22.15]
105309227  [KO:K06752]
105309961  ATP6V1D; V-type proton ATPase subunit D [KO:K02149]
105310204  [KO:K06752]
105310338  [KO:K06752]
Compound
C00080  H+
C00584  Prostaglandin E2
C05443  Vitamin D3
Reference
  Authors
Zwerina J, Redlich K, Schett G, Smolen JS
  Title
Pathogenesis of rheumatoid arthritis: targeting cytokines.
  Journal
Ann N Y Acad Sci 1051:716-29 (2005)
DOI:10.1196/annals.1361.116
Reference
  Authors
Szekanecz Z, Vegvari A, Szabo Z, Koch AE
  Title
Chemokines and chemokine receptors in arthritis.
  Journal
Front Biosci (Schol Ed) 2:153-67 (2010)
DOI:10.2741/53
Reference
  Authors
Isaacs JD
  Title
The changing face of rheumatoid arthritis: sustained remission for all?
  Journal
Nat Rev Immunol 10:605-11 (2010)
DOI:10.1038/nri2804
Reference
  Authors
Strand V, Kimberly R, Isaacs JD
  Title
Biologic therapies in rheumatology: lessons learned, future directions.
  Journal
Nat Rev Drug Discov 6:75-92 (2007)
DOI:10.1038/nrd2196
Reference
  Authors
Bartok B, Firestein GS
  Title
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.
  Journal
Immunol Rev 233:233-55 (2010)
DOI:10.1111/j.0105-2896.2009.00859.x
Reference
  Authors
Dai SM, Shan ZZ, Xu H, Nishioka K
  Title
Cellular targets of interleukin-18 in rheumatoid arthritis.
  Journal
Ann Rheum Dis 66:1411-8 (2007)
DOI:10.1136/ard.2006.067793
Reference
PMID:9627005
  Authors
Koch AE
  Title
Review: angiogenesis: implications for rheumatoid arthritis.
  Journal
Arthritis Rheum 41:951-62 (1998)
DOI:10.1002/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D
Reference
  Authors
Szekanecz Z, Besenyei T, Szentpetery A, Koch AE
  Title
Angiogenesis and vasculogenesis in rheumatoid arthritis.
  Journal
Curr Opin Rheumatol 22:299-306 (2010)
DOI:10.1097/BOR.0b013e328337c95a
Reference
  Authors
Brunner-Weinzierl MC, Hoff H, Burmester GR
  Title
Multiple functions for CD28 and cytotoxic T lymphocyte antigen-4 during different phases of T cell responses: implications for arthritis and autoimmune diseases.
  Journal
Arthritis Res Ther 6:45-54 (2004)
DOI:10.1186/ar1158
Reference
  Authors
Theill LE, Boyle WJ, Penninger JM
  Title
RANK-L and RANK: T cells, bone loss, and mammalian evolution.
  Journal
Annu Rev Immunol 20:795-823 (2002)
DOI:10.1146/annurev.immunol.20.100301.064753
Reference
  Authors
Mensah KA, Li J, Schwarz EM
  Title
The emerging field of osteoimmunology.
  Journal
Immunol Res 45:100-13 (2009)
DOI:10.1007/s12026-009-8093-x
Reference
  Authors
Takayanagi H, Sato K, Takaoka A, Taniguchi T
  Title
Interplay between interferon and other cytokine systems in bone metabolism.
  Journal
Immunol Rev 208:181-93 (2005)
DOI:10.1111/j.0105-2896.2005.00337.x
Reference
  Authors
Takayanagi H
  Title
New immune connections in osteoclast formation.
  Journal
Ann N Y Acad Sci 1192:117-23 (2010)
DOI:10.1111/j.1749-6632.2009.05303.x
Reference
  Authors
Nakashima T, Takayanagi H
  Title
Osteoimmunology: crosstalk between the immune and bone systems.
  Journal
J Clin Immunol 29:555-67 (2009)
DOI:10.1007/s10875-009-9316-6
Reference
  Authors
Nakashima T, Takayanagi H
  Title
Osteoclasts and the immune system.
  Journal
J Bone Miner Metab 27:519-29 (2009)
DOI:10.1007/s00774-009-0089-z
Reference
  Authors
Takayanagi H
  Title
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.
  Journal
Nat Rev Immunol 7:292-304 (2007)
DOI:10.1038/nri2062
Reference
  Authors
Fox DA, Gizinski A, Morgan R, Lundy SK
  Title
Cell-cell interactions in rheumatoid arthritis synovium.
  Journal
Rheum Dis Clin North Am 36:311-23 (2010)
DOI:10.1016/j.rdc.2010.02.004
Reference
  Authors
Rho J, Takami M, Choi Y
  Title
Osteoimmunology: interactions of the immune and skeletal systems.
  Journal
Mol Cells 17:1-9 (2004)
Related
pathway
pvp04370  VEGF signaling pathway
pvp04380  Osteoclast differentiation
pvp04620  Toll-like receptor signaling pathway
pvp04659  Th17 cell differentiation
pvp04660  T cell receptor signaling pathway
pvp04670  Leukocyte transendothelial migration
KO pathway
ko05323   

DBGET integrated database retrieval system